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Abstract We have isolated two human ubiquitin-like (UbL)
proteins that bind to a short peptide within the ATPase domain
of the Hsp70-like Stch protein. Chap1 is a duplicated homologue
of the yeast Dsk2 gene that is required for transit through the
G2/M phase of the cell cycle and expression of the human full-
length cDNA restored viability and suppressed the G2/M arrest
phenotype of dsk2v rad23v Saccharomyces cerevisiae mutants.
Chap2 is a homologue for Xenopus scythe which is an essential
component of reaper-induced apoptosis in egg extracts. While the
N-terminal UbL domains were not essential for Stch binding,
Chap1/Dsk2 contains a Sti1-like repeat sequence that is required
for binding to Stch and is also conserved in the Hsp70 binding
proteins, Hip and p60/Sti1/Hop. These findings extend the
association between Hsp70 members and genes encoding UbL
sequences and suggest a broader role for the Hsp70-like ATPase
family in regulating cell cycle and cell death events.
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1. Introduction
The Hsp70-like gene family encodes a group of related pro-
tein chaperones that are required for the viability of all living
organisms. The structure of all Hsp70 proteins is similar and
consists of a highly conserved 45 kDa N-terminal ATPase
domain and a 25 kDa C-terminal domain that functions to
reversibly capture nascent or denatured cellular polypeptides
to initiate a wide range of protein processing events [1^3]. The
complexity of Hsp70 activity has become increasingly appar-
ent with the recognition that they interact with other co-chap-
erones, including Hsp40, Hsp90, and p60/Sti1, to form a func-
tional unit [4]. In addition, non-chaperone ‘Hsp70 interacting
proteins’ have been identi¢ed which are required for regulat-
ing protein folding and/or ATPase activity [5^11].
In contrast to the bi-functional structure of Hsp70 family
members, a novel gene product was isolated, designated Stch,
which encodes the ‘core ATPase’ domain of Hsp70 but lacks
the peptide binding domain [12]. The truncated structure of
Stch is conserved in Caenorhabditis elegans, rat, and human
tissues where it was observed to resemble a proteolytically
cleaved N-terminal ATPase fragment of Hsc70/Hsp70 [13].
To study the role of the Stch product in regulating protein
processing, we performed a two-hybrid screen. We isolated
multiple, overlapping human cDNA clones that encode dis-
tinct, ubiquitin-related proteins that bound e⁄ciently to a
conserved 20 amino acid region within the Stch ATPase do-
main. Analysis of the Chap1/Dsk2 gene showed that it is a
homologue of the Saccharomyces cerevisiae DSK2 gene,
which, together with RAD23, is important for the proper
organization of the yeast mitotic spindle and transit through
mitosis [14]. In contrast, Chap2 represents the human Bat3
gene [15] and is a homologue of the Xenopus scythe gene
which is essential for reaper-induced apoptosis [16]. The iden-
ti¢cation of ubiquitin-linked proteins that bind to a conserved
peptide motif within the ‘core ATPase’ Stch molecule suggests
a broader role for Hsp70 family members in regulating speci-
alized cellular events.
2. Materials and methods
2.1. Isolation of Stch binding proteins
Human Stch cDNA (codons 2^467) was subcloned in-frame into
the pGBT9 Gal4p DNA binding domain plasmid (Clontech, Palo
Alto, CA, USA). The HF7c yeast strain was transformed with the
pGBT9-Stch plasmid followed by sequential transformation of a hu-
man lung cDNA library fused to the pGad10 Gal4p activation do-
main plasmid. Plasmids were isolated from yeast transformants on
-L/W/H plates and subjected to nucleotide sequencing. Yeast strains
were re-transformed with puri¢ed plasmids and multiple independent
transformants were tested to con¢rm protein binding by L-galactosi-
dase enzyme activity and by growth on SC-His media in all cases.
2.2. Functional analyses of Chap1/Dsk2
Yeast media and general techniques were as described previously
[17]. Wild-type S. cerevisiae strain, MY3492, and the dsk2v rad23v
mutant strain, MY5156, were transformed with: pMR3429, pGAL
vector alone; pMR2757 DSK2 CEN [14]; pMR4647 (pGAL-human
Chap1/Dsk2); pMR2905, pGAL-DSK2 ; and pMR2906, pGAL-DSK2-
1. Serial dilutions of transformants were incubated at the permissive
or restrictive temperature and in the presence or absence of galactose
and scored for growth [17]. Cultures of yeast transformants were also
grown in SC-ura galactose medium until early logarithmic phase at
30‡C and were shifted to 37‡C for 10 h. Cells were ¢xed with meth-
anol:acetone (3:1 ratio) on ice for 30 min and stained with DAPI on
ice for 30 min. Greater than 100 cells were counted for each culture.
2.3. GST-Stch pull-down analysis with endogenous Bat3/Scythe
Glutathione-S-transferase (GST) and GST-fusion proteins were pu-
ri¢ed in Escherichia coli on glutathione-Sepharose beads as previously
described [18], blocked with 10 Wg/ml bovine serum albumin for
30 min, and washed three times in egg lysis bu¡er (ELB: 250 mM
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sucrose, 2.5 mM MgCl2, 1 mM dithiothreitol, 50 mM KCl, 10 mM
HEPES pH 7.4). A crude Xenopus egg extract was prepared in ELB as
previously described [16] and added to the GST-fusion proteins at
10Uthe bead volume. Following a 60 min incubation at 4‡C, the
GST-fusion proteins were pelleted and washed three times in ELB.
The washed pellets were resolved by SDS^PAGE and subjected to
protein immunoblotting using 1:500 dilution of an K-Scythe antisera
raised against the carboxy-terminal 16 amino acids of the X. scythe
protein.
2.4. Protein sequence analysis
The non-redundant database of protein sequences at the National
Center for Biotechnology Information (NCBI, NIH, Bethesda, MD,
USA) was tested using the gapped BLASTP program and the Posi-
tion-Speci¢c Iterating (PSI) BLAST program [19]. Conserved signal-
ing and interaction domains in protein sequences were identi¢ed using
the SMART searching engine [20]. Multiple sequence alignments were
constructed using the Clustal W program [21]. The accession numbers
for the amino acid sequences used: S. cerevisiae DSK2 (P48510),
S. cerevisiae SSA4 (P22202), human Stch (U04735), and human BiP
(P11021).
3. Results and discussion
We obtained several HF7c His+ transformants after screen-
ing a human lung two-hybrid cDNA library using a pGBT9-
Stch bait plasmid. Three overlapping clones were isolated for
Fig. 1. A: Amino acid sequence of the human Chap1/Dsk2 gene. The conserved ubiquitin domain (from residues 33 to 101) is overlined and is
preceded by a 21 residue leader peptide; the conserved UbA domain is overlined by a broken line; the repeats resembling the C-terminal region
of S. cerevisiae Sti1 and rat Hip are indicated by an open rectangle. B: Diagram of the alignment with the yeast DSK2 gene (yDsk2) showing
duplication of the human homologue. The ubiquitin domain is depicted as a black rectangle, the UbA domain (aa 326^369 in yDsk2; aa 578^
620 in Chap1/Dsk2) is identi¢ed, and the minimal sequence for Stch binding (aa 319^520) is shown as a stippled rectangle. GenBank accession
number is AF189009.
Fig. 2. The human Chap1/Dsk2 gene suppressed the dsk2v rad23v phenotype. Serial dilutions of wild-type or temperature-sensitive dsk2v
rad23v mutant yeast colonies were grown at the permissive or restrictive temperatures as indicated. The yeast colonies contained either wild-
type yeast DSK2 (yDSK2), dominant mutant yeast DSK2 (yDSK2-1), the human Chap1/Dsk2 (hDsk2), or the empty vector. All of the DSK2
genes were expressed as galactose-inducible proteins.
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the Chap1 gene, one of which represented a full-length cDNA
spanning 3360 nucleotides and encoding an open reading
frame of 624 residues (Fig. 1). A Blastp search [22] revealed
that this gene represented the human homologue for the yeast
DSK2 gene [14]. Inspection of the amino acid alignment be-
tween the human and yeast homologues shows that the hu-
man gene encodes a 21 residue leader peptide, resembling a
mitochondrial import sequence, followed by a conserved 70
amino acid, ubiquitin-like (UbL) domain at the amino-termi-
nal end. Chap1/Dsk2, however, is approximately twice the size
of the yeast homologue, apparently resulting from a duplica-
tion of the yeast sequence distal to the UbL domain. In addi-
tion, both the yeast and human genes contain a ubiquitin-
associated (UbA) domain at their C-termini [23].
Neither the N-terminal UbL domain nor the C-terminal
UbA domain of Chap1/Dsk2 were required for binding to
Stch and the smallest cDNA clone isolated in our screen
spanned 200 residues of one monomer DSK2 unit suggesting
that the duplication of the yeast sequence was not essential for
Stch binding. Interestingly, this minimal binding domain con-
tained two Sti1-like repeat sequences with strong sequence
similarity to the conserved C-terminal domain of the chaper-
one binding proteins p60/Sti1 and Hip [24] (Fig. 1) (Chap1
residues: 190^237, 360 to 412, and 433^460 align with the S.
cerevisiae Sti1 residues: 149^191 and 540 to 579) that in Sti11
is implicated in Hsp70 and Hsp90 binding [24,25]. We ob-
served that an in-frame deletion of Chap1/Dsk2 removing
amino acid residues 418 to 431 that lie between the last two
Sti1 repeat sequences within the minimal binding region had
no e¡ect on Stch binding using the yeast two-hybrid binding
assay. In contrast, a carboxy-terminal deletion that disrupted
only the ¢nal Sti1 repeat sequence showed complete loss of
Stch binding (data not shown) suggesting that this region is
required for binding to the ATPase domain of Stch. In addi-
tion, the minimal binding domain of Chap1/Dsk2 spans a 55
residue glycine/proline collagen-like repeat region which re-
sembles, but is distinct, from the GGMP repeat observed in
the Hip product [24].
To examine the functional activity of Chap1/Dsk2, a tem-
perature-sensitive dsk2v rad23v S. cerevisiae strain (MY5156)
was tested for cell growth following transformation with the
full-length yeast DSK2 gene (yDsk2), a dominant yeast DSK2
mutation in the ubiquitin domain (yDSK2-1), the human
Chap1/Dsk2 cDNA (hDsk2), or the vector alone (Fig. 2).
All of the proteins were expressed under the control of the
GAL1 galactose-inducible promoter. While single mutants for
either dsk2v or rad23v do not exhibit cell growth defects at
37‡C, double mutants at the restrictive temperature are ar-
rested at G2/M with defects in duplication of the mitotic
spindle pole body [14]. We observed that high levels of
yDSK2 and yDSK2-1 expression were toxic in wild-type
S. cerevisiae cells [14]. However, as reported previously,
when expressed under its own promoter, yDSK2 could reverse
the block at G2/M observed in dsk2v rad23v cells (Fig. 3 and
data not shown) [14]. Following galactose induction, the hu-
man Chap1/Dsk2 gene e⁄ciently suppressed the growth arrest
of the dsk2v rad23v cells, and, in contrast to yeast DSK2,
high level expression of the human homologue was not toxic
to wild-type cells. In addition, we analyzed the cell cycle dis-
tribution of the dsk2v rad23v transformants following 10 h
incubation at the restrictive temperature. We observed a re-
duction in the frequency of ‘aberrant’ large-budded cells at
G2/M in cells transformed with the human Chap1/Dsk2
cDNA clone, con¢rming the ability of the human homologue
to complement the dsk2v rad23v defect (Fig. 3). These results
indicate that the sequence conservation between the yeast and
human proteins extends to functional conservation.
Fig. 3. The human Chap1/Dsk2 gene suppresses the G2/M arrest
phenotype of dsk2v rad23v. Strain MY5156 (dsk2v rad23v) was
transformed with the indicated plasmids as described in Section 2.
Cell types shown are (left to right): unbudded G1 phase cells,
small-budded S/G2 phase cells, large-budded G2/M phase cells, and
large-budded post-mitotic cells.
Fig. 4. Chap1/Dsk2 binds to a conserved peptide at the carboxy-terminal end of the ATPase domain. A: Diagram of Stch peptide clones. ++
indicates strongly positive L-galactosidase activity and abundant growth on SC-His media. 3 indicates absent L-galactosidase activity and no
growth on SC-His plates after 4 days of incubation. B: Partial amino acid sequence alignment showing human Stch (hStch), human BiP/Grp78
(hBip), and the S. cerevisiae Hsp70 product SSA4. The terminal, conserved region of the Hsp70-like ATPase domain is boxed with the corre-
sponding Stch clones overlined.
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To test the speci¢city of the binding interaction with the
ATPase domain of Stch, we used the two-hybrid technique to
map the binding site for Chap1/Dsk2 on the Stch protein (Fig.
4). Using both L-galactosidase activity and growth on SC-His
plates, we observed that a series of carboxy-terminal Stch
truncations showed loss of protein binding. Since Stch con-
tains a unique carboxy-terminal sequence that is conserved in
all Stch homologues, but not shared with other Hsp70 mem-
bers [13], we designed two peptide sequences that would either
include the C-terminal 30 amino acid residues that are con-
served in all Hsp70 members (clone 7) or would include
unique Stch sequences (clone 8). We observed that clone 7
bound Chap1/Dsk2 with the same e⁄ciency as full-length
Stch, while the smaller peptide containing Stch-speci¢c, C-ter-
minal sequences had no binding activity. Therefore, Stch
binds Chap1/Dsk2 via a region that is highly conserved in
Hsp70 proteins.
The interaction of Chap1/Dsk2 with the ATPase domain of
Stch resembles the properties of the Bag1/Rap46 protein
which also contains an N-terminal UbL domain and was re-
cently shown to bind to the ATPase domain of 70 kDa heat
shock proteins [5,11]. We have also isolated multiple cDNA
clones for another UbL containing gene, designated Chap2,
that bound e⁄ciently to pGBT9-Stch in the two-hybrid
screen. Chap2 represented the human homologue for the
Bat3/Scythe gene [15,16] and exhibits several similarities
with Chap1/Dsk2 including the presence of an N-terminal
UbL domain which was again not required for Stch binding
and showed an identical pattern of binding exclusively to the
short conserved motif localized on Stch ATPase peptide 7
(Fig. 4).
To con¢rm the Scythe-Stch interaction, we tested the bind-
ing of endogenous X. scythe to either GST alone, the previ-
ously reported Scythe ligand, GST-reaper [16], or to either
human or rat GST-Stch (Fig. 5). We found that both rat
and human Stch precipitated Scythe from Xenopus egg ex-
tracts with an e⁄ciency similar to the pro-apoptosis Droso-
phila reaper product (GST-rpr), while the GST leader peptide
had no Scythe binding activity. We also demonstrated binding
of endogenous Scythe to full-length Xenopus Hsc70 suggesting
a more general role for this binding interaction (Fig. 5). These
observations demonstrate that the ATPase domain of Hsp70-
like members binds to a family of at least three ubiquitin-
linked proteins, including Chap1/Dsk2, Chap2/Scythe, and
Bag1/Rap46.
The role for these interactions with UbL-linked proteins,
however, is still unknown. The best-characterized UbL-linked
protein is Rad23p, which controls UV sensitivity [26,27], reg-
ulates Rad4p activity, and directly interacts with the 26S pro-
teasome through its amino-terminal ubiquitin domain [28].
Since Rad23p binds to the Rad4p DNA repair protein
through its carboxy-terminal region [29], this protein repre-
sents a direct link between DNA repair and the ubiquitin/
proteasome pathways [28]. While we have shown that
Rad23 and Chap1/Dsk2 share conserved UbL and UbA do-
mains [23,30] and are functionally redundant for the ability to
complement cell growth in dsk2v and rad23v S. cerevisiae
cells, there is no evidence to date that either Chap1/Dsk2,
Scythe, or Bag1/Rap46 are associated with the proteasome.
In the case of Bag1/Rap46, recent studies have shown that
the binding of Bag1/Rap46 with Hsp/Hsc70 serves to both
inhibit chaperone activity and to mediate multimeric protein
complexes that include the anti-apoptosis molecule, Bcl-2, the
nuclear oncogene, c-jun, as well as several hormone and
growth factor receptors [5,9,11]. These observations suggested
that Bag1/Rap46 may serve to regulate the cellular stress re-
sponse and provide a link with cell signalling and the cell
death machinery. Although we have not yet de¢ned the sub-
cellular localization and the speci¢c functional role for Chap1/
DSk2 and Chap2/Scythe, we have now identi¢ed two addi-
tional ubiquitin-linked proteins that retain the capacity to
bind to the ATPase domain of an Hsp70-like molecule and
which can modulate, respectively, transit through the G2/M
phase of the cell cycle or the apoptotic machinery. Of interest,
a recently identi¢ed Hsp70 interacting protein, CHIP [7] also
encodes a discrete ubiquitin box domain (U-box) identi¢ed in
a novel ubiquitin conjugation factor involved in multiubiqui-
tin assembly and cell survival under stress conditions [31].
These ¢ndings propose a broader role for the Hsp70-like fam-
ily in regulating cell cycle and cell death events.
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